Emerging Community-Acquired Methicillin-Resistant Staphylococcus Aureus Pneumonia

被引:0
|
作者
Orlovic, Dragana [1 ,2 ]
Smego, Raymond A. [3 ]
机构
[1] Lawnwood Reg Med Ctr, Ft Pierce, FL 34950 USA
[2] Heart Inst, Ft Pierce, FL USA
[3] Commonwealth Med Coll, Scranton, PA 18503 USA
关键词
Pneumonia; community-acquired; Staphylococcus aureus; MRSA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Methicillin-resistant Staphylococcus aureus (MRSA) has been an important nosocomial pathogen worldwide for more than four decades. Community-acquired MRSA infections, generally occurring in previously healthy persons without recognizable risk factors for health care setting-related MRSA, are emerging as serious clinical and public health concerns. The most frequent of these community-based infections include skin and soft tissue infections and necrotizing pneumonias. A majority of causative community-acquired MRSA (CA-MRSA) isolates are associated with genes that encode the virulence factor, Panton-Valentine leukocidin (PVL) toxin. Aims & Objectives: To describe six cases of CA-MRSA pneumonia recently admitted to our community hospital in Florida, and discuss the epidemiology, clinical features, and management of these expanding infections. Methods/Study Design: The medical records of six patients with radiographically-confirmed pneumonia and positive sputum cultures for MRSA at the time of hospitalization at the Lawnwood Regional Medical Center and Heart Institute, Fort Pierce, Florida, from December 2006 through January 2007, were retrospectively reviewed. All patients were seen by one of the authors (DO), an infectious diseases consultant. Lawnwood Regional Medical Center is a 341-bed, acute care institution and regional referral center for four counties of Treasure Coast, FL. The hospital institution review board gave permission for this study. Results/Findings: Six patients (5 men, 1 woman) with CA-MRSA pneumonia were identified. The mean patient age was 57 years (range, 32-79 years). Three patients had no history of previous hospital admission, while two patients had been last hospitalized two years prior to the study admission. Three elderly patients had known co-morbidities predisposing to pneumonia including carcinoma of the lung (2 patients), and cirrhosis, diabetes mellitus, chronic renal failure, COPD, and cardiomyopathy (1 patient each). Sputum samples were collected at the time of admission and all grew MRSA. Two isolates were resistant only to oxacillin, while four were also resistant to levofloxacin (3 isolates), erythromycin (2 isolates), ciprofloxacin (1 isolate), and/or clindamycin (1 isolate). One patient had concurrent Pseudomonas bacteremia, and another had Pseudomonas isolated from sputum culture in addition to MRSA. All patients had abnormal chest radiographs; three had focal unilateral pneumonia, two had bilateral pneumonia, and one had a lung abscess. The latter patient also had evidence of metastatic infection with sternoclavicular osteomyelitis. Three patients required ventilatory support; two of these subjects died and one was discharged to hospice care. None of the six patients had any epidemiologic connection to one another. Conclusion: CA-MRSA is becoming an increasingly important cause of community-acquired pneumonia in many parts of the world, and in these regions empiric antibiotic treatment guidelines should be reconsidered.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 50 条
  • [1] Necrotizing pneumonia by community-acquired, methicillin-resistant Staphylococcus aureus in Colombia
    Hernando Gomez, Carlos
    Maria Perilla, Ana
    Gonzalez, Camilo
    Liliana Valderrama, Sandra
    Vanegas, Natasha
    Chavarro, Bibiana
    Carlos Triana, Luis
    Roberto Tamara, Jose
    Arturo Alvarez, Carlos
    BIOMEDICA, 2009, 29 (04): : 523 - 530
  • [2] Community-acquired methicillin-resistant Staphylococcus aureus infections
    Maltezou, HC
    Giamarellou, H
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (02) : 87 - 96
  • [3] Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics
    Buescher, ES
    CURRENT OPINION IN PEDIATRICS, 2005, 17 (01) : 67 - 70
  • [4] Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: A clinical audit
    Thomas, Rajesh
    Ferguson, John
    Coombs, Geoffrey
    Gibson, Peter G.
    RESPIROLOGY, 2011, 16 (06) : 926 - 931
  • [5] Case of rapidly progressive necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus
    Dickson, Robert P.
    Martinez, Shay M.
    Ortiz, Justin R.
    RESPIRATORY CARE, 2008, 53 (09) : 1223 - 1226
  • [6] Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children
    Marcinak, JF
    Frank, AL
    CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (03) : 265 - 269
  • [7] Community-acquired methicillin-resistant Staphylococcus aureus infections in children
    Antoinette Frick, Marie
    Moraga-Llop, Fernando A.
    Bartolome, Rosa
    Larrosa, Nieves
    Campins, Magda
    Roman, Yuani
    Vindel, Ana
    Figueras, Concepcio
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (10): : 675 - 679
  • [8] Managing Severe Community-Acquired Pneumonia Due to Community Methicillin-Resistant Staphylococcus aureus (MRSA)
    Jason C. Kwong
    Kyra Chua
    Patrick G. P. Charles
    Current Infectious Disease Reports, 2012, 14 : 330 - 338
  • [9] Comparison of Methicillin-Resistant Staphylococcus aureus Community-Acquired and Healthcare-Associated Pneumonia
    Leem, Ah Young
    Jung, Won Jai
    Kang, Young Ae
    Park, Seon Cheol
    Kim, Young Jae
    Hwang, Eu Dong
    Kim, Eun Young
    Jung, Kyung Soo
    Park, Moo Suk
    Kim, Song Yee
    Kim, Young Sam
    Kim, Se Kyu
    Chang, Joon
    Jung, Ji Ye
    YONSEI MEDICAL JOURNAL, 2014, 55 (04) : 967 - 974
  • [10] Clinical features and outcome of community-acquired methicillin-resistant Staphylococcus aureus pneumonia
    Obed, Mora
    Garcia-Vidal, Carolina
    Pessacq, Pedro
    Mykietiuk, Analia
    Viasus, Diego
    Cazzola, Laura
    Angeles Dominguez, M.
    Calmaggi, Anibal
    Carratala, Jordi
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2014, 32 (01): : 23 - 27